CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.45BCNY514.76M · vs all stocks (USD)
Revenue (TTM)
319.79MCNY47.74M · vs all stocks (USD)
Profit Margin
-9.27%vs Medical Devices peers
Beta
0.4270xvs all stocks
52-Week Change
23.95%vs all stocks
Market Capitalization
3.45BCNY514.76M · vs all stocks (USD)
Enterprise Value
3.58BCNY534.24M · vs all stocks (USD)
Forward P/E
63.42xvs Medical Devices peers
Price to Sales (TTM)
10.78xvs Medical Devices peers
Price to Book (MRQ)
4.22xvs Medical Devices peers
Enterprise to Revenue
11.19xvs Medical Devices peers
Enterprise to EBITDA
-197.47xvs Medical Devices peers
Gross Margin
32.24%vs Medical Devices peers
Profit Margin
-9.27%vs Medical Devices peers
Operating Margin
-16.75%vs Medical Devices peers
Return on Assets (TTM)
-1.36%vs Medical Devices peers
Return on Equity (TTM)
-3.70%vs Medical Devices peers
Revenue (TTM)
319.79MCNY47.74M · vs all stocks (USD)
Revenue per Share (TTM)
3.54CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-12.90%vs Medical Devices peers
Gross Profit (TTM)
101.40MCNY15.14M · vs all stocks (USD)
EBITDA (TTM)
21.30MCNY3.18M · vs all stocks (USD)
Net Income (TTM)
-29.64MCNY-4.42M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
28.82%vs Medical Devices peers
Operating Cash Flow (TTM)
-40.74MCNY-6.08M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
24.07MCNY3.59M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
-803.12KCNYFY2025 · Dec 31, 2025Revenue
320.86MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
203.30MCNYFY2025 · Dec 31, 2025Gross Profit
117.56MCNYFY2025 · Dec 31, 2025Operating Income
19.99MCNY2.98M · vs all stocks (USD)
Pre-tax Income
-9.48MCNYFY2025 · Dec 31, 2025Income Tax Expense
-2.16MCNYFY2025 · Dec 31, 2025Net Income
-7.33MCNYFY2025 · Dec 31, 2025EBIT
-8.53MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
21.30MCNYFY2025 · Dec 31, 2025Research & Development
32.05MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
20.38MCNYFY2025 · Dec 31, 2025Other Operating Expenses
1.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
675.78KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
950.25KCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0800CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
83.34MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
83.34MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-7.33MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
662.13KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-113.21MCNYFY2025 · Dec 31, 2025Free Cash Flow
-178.88MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
212.02MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-7.33MCNYFY2025 · Dec 31, 2025Other Non-cash Items
5.72MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-32.04MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-79.56MCNYFY2025 · Dec 31, 2025Capital Expenditures
-65.67MCNYFY2025 · Dec 31, 2025Purchase of Investments
-38.00MCNYFY2025 · Dec 31, 2025Sale of Investments
4.55MCNYFY2025 · Dec 31, 2025Other Investing Activity
144.36MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
45.23MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
67.34MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-37.59MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-5.95MCNYFY2025 · Dec 31, 2025Other Financing Charges
-4.29MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
19.50MCNYFY2025 · Dec 31, 2025Shares Outstanding
88.13MSharesUpdated Sep 22, 2026Float Shares
59.43MSharesUpdated Sep 22, 2026% Held by Insiders
39.82%vs all stocks
% Held by Institutions
8.24%vs all stocks
Total Cash (MRQ)
269.78MCNY40.27M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.09CNYUpdated Sep 22, 2026Total Debt (MRQ)
366.13MCNY54.65M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4063xvs Medical Devices peers
Current Ratio (MRQ)
1.92xvs Medical Devices peers
Book Value per Share (MRQ)
9.28CNYUpdated Sep 22, 2026Total Assets
977.93MCNY145.98M · vs all stocks (USD)
Total Current Assets
532.17MCNYFY2025 · Dec 31, 2025Total Liabilities
124.52MCNYFY2025 · Dec 31, 2025Total Non-current Assets
445.75MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
13.08MCNYFY2025 · Dec 31, 2025Total Current Liabilities
111.44MCNYFY2025 · Dec 31, 2025Cash
212.02MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.39MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
213.41MCNYFY2025 · Dec 31, 2025Other Short-term Investments
30.04MCNYFY2025 · Dec 31, 2025Accounts Receivable
111.55MCNYFY2025 · Dec 31, 2025Inventory
151.75MCNYFY2025 · Dec 31, 2025Accounts Payable
57.17MCNYFY2025 · Dec 31, 2025Short-term Debt
35.71MCNYFY2025 · Dec 31, 2025Other Current Liabilities
542.76KCNYFY2025 · Dec 31, 2025Long-term Debt
6.77MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.02MCNYFY2025 · Dec 31, 2025Common Stock (Book)
88.13MCNYFY2025 · Dec 31, 2025Retained Earnings
189.54MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
853.41MCNY127.39M · vs all stocks (USD)
Treasury Stock
10.00MCNYFY2025 · Dec 31, 202552-Week Low
25.80CNYUpdated Sep 22, 202652-Week High
73.00CNYUpdated Sep 22, 202652-Week Change
23.95%vs all stocks
Beta
0.4270xvs all stocks
50-Day MA
40.46CNYUpdated Sep 22, 2026200-Day MA
51.93CNYUpdated Sep 22, 2026Avg 10-Day Volume
923.61KSharesUpdated Sep 22, 2026Avg 30-Day Volume
1.39MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.3400CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Oculis Holding AG
Tier 1ProductionApproval-Gated PipelineRule
Tactile Systems Technology Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sd Biosensor Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai ZJ Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Hanbon Science & Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aim Vaccine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Succeeder Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Crescent Biopharma, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Eiken Chemical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Bright Minds Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Hyliion Holdings Corp.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Jade Biosciences Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Weihai Huadong Automation Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated